NM_001033855.3:c.1795A>G
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001033855.3(DCLRE1C):c.1795A>G(p.Lys599Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001033855.3 missense
Scores
Clinical Significance
Conservation
Publications
- Omenn syndromeInheritance: AR Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: G2P, Ambry Genetics, Orphanet
- severe combined immunodeficiency due to DCLRE1C deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001033855.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DCLRE1C | NM_001033855.3 | MANE Select | c.1795A>G | p.Lys599Glu | missense | Exon 14 of 14 | NP_001029027.1 | ||
| DCLRE1C | NM_001289076.2 | c.1450A>G | p.Lys484Glu | missense | Exon 12 of 12 | NP_001276005.1 | |||
| DCLRE1C | NM_001289078.2 | c.1450A>G | p.Lys484Glu | missense | Exon 12 of 12 | NP_001276007.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DCLRE1C | ENST00000378278.7 | TSL:1 MANE Select | c.1795A>G | p.Lys599Glu | missense | Exon 14 of 14 | ENSP00000367527.2 | ||
| DCLRE1C | ENST00000357717.6 | TSL:1 | n.*1453A>G | non_coding_transcript_exon | Exon 12 of 12 | ENSP00000350349.3 | |||
| DCLRE1C | ENST00000378246.6 | TSL:1 | n.*1412A>G | non_coding_transcript_exon | Exon 13 of 13 | ENSP00000367492.3 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD2 exomes AF: 0.00000796 AC: 2AN: 251264 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461884Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Severe combined immunodeficiency due to DCLRE1C deficiency Uncertain:1
This sequence change replaces lysine with glutamic acid at codon 599 of the DCLRE1C protein (p.Lys599Glu). The lysine residue is weakly conserved and there is a small physicochemical difference between lysine and glutamic acid. This variant is present in population databases (rs760292491, ExAC 0.003%). This variant has not been reported in the literature in individuals affected with DCLRE1C-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at